AIMEDIC Publications

The three-dimensionality of the hiPSC-CM spheroid contributes to the variability of the field potential

Category

Pub

Date

2023-03-21

Source

Frontiers in Physiology

Background: Field potential (FP) signals from human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) spheroid which are used for drug safety tests in the preclinical stage are different from action potential (AP) signals and require working knowledge of the multi-electrode array (MEA) system. In this study, we developed in silico three-dimensional (3-D) models of hiPSC-CM spheroids for the simulation of field potential measurement. We compared our model simulation results against in vitro experimental data under the effect of drugs E-4031 and nifedipine.

Content update: API publication dates are used first. Review the abstract, source link, product intended use, and limitations together.